Proteomics for Cerebrospinal Fluid Biomarker Identification in Parkinsons Disease: Methods and Critical Aspects

Antonio Conti, Massimo Alessio
2015 AIMS Medical Science  
Parkinson's disease (PD), similar with other neurodegenerative disorders, would benefit from the identification of early biomarkers for differential diagnosis and prognosis to address prompt clinical treatments. Together with hypothesis driven approaches, PD has been investigated by high-throughput differential proteomic analysis of cerebrospinal fluid (CSF) protein content. The principal methodologies and techniques utilized in the proteomics field for PD biomarker discovery from CSF are
more » ... from CSF are presented in this mini review. The positive aspects and challenges in proteome-based biomarker research are also discussed.
doi:10.3934/medsci.2015.1.1 fatcat:wb2fliwvtvcbznha2s25ggbata